• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Coll Emerg Physicians Open . The low-harm score for predicting mortality in patients diagnosed with COVID-19: A multicentric validation study

tetano

Editor, Senior Moderator
J Am Coll Emerg Physicians Open


. 2020 Oct 15;10.1002/emp2.12259.
doi: 10.1002/emp2.12259. Online ahead of print.
The low-harm score for predicting mortality in patients diagnosed with COVID-19: A multicentric validation study


Adrian Soto-Mota[SUP] 1 [/SUP], Braulio A Marfil-Garza[SUP] 2 [/SUP], Erick Mart?nez Rodr?guez[SUP] 2 [/SUP], Jos? Omar Barreto Rodr?guez[SUP] 3 [/SUP], Alicia Estela L?pez Romo[SUP] 4 [/SUP], Paolo Alberti Minutti[SUP] 5 [/SUP], Juan Vicente Alejandre Loya[SUP] 6 [/SUP], F?lix Emmanuel P?rez Talavera[SUP] 6 [/SUP], Freddy Jos? ?vila Cervera[SUP] 7 [/SUP], Adriana Velazquez Burciaga[SUP] 8 [/SUP], Oscar Morado Aramburo[SUP] 9 [/SUP], Luis Alberto Pi?a Olgu?n[SUP] 10 [/SUP], Adrian Soto-Rodr?guez[SUP] 11 [/SUP], Andr?s Casta?eda Prado[SUP] 12 [/SUP], Patricio Santill?n Doherty[SUP] 3 [/SUP], Juan O Galindo[SUP] 4 [/SUP], Luis Alberto Gu?zar Garc?a[SUP] 5 [/SUP], Daniel Hern?ndez Gordillo[SUP] 6 [/SUP], Juan Guti?rrez Mej?a[SUP] 2 [/SUP]



Affiliations

Abstract

Objective: We sought to determine the accuracy of the LOW-HARM score (Lymphopenia, Oxygen saturation, White blood cells, Hypertension, Age, Renal injury, and Myocardial injury) for predicting death from coronavirus disease 2019) COVID-19.
Methods: We derived the score as a concatenated Fagan's nomogram for Bayes theorem using data from published cohorts of patients with COVID-19. We validated the score on 400 consecutive COVID-19 hospital admissions (200 deaths and 200 survivors) from 12 hospitals in Mexico. We determined the sensitivity, specificity, and predictive values of LOW-HARM for predicting hospital death.
Results: LOW-HARM scores and their distributions were significantly lower in patients who were discharged compared to those who died during their hospitalization 5 (SD: 14) versus 70 (SD: 28). The overall area under the curve for the LOW-HARM score was 0.96, (95% confidence interval: 0.94-0.98). A cutoff > 65 points had a specificity of 97.5% and a positive predictive value of 96%.
Conclusions: The LOW-HARM score measured at hospital admission is highly specific and clinically useful for predicting mortality in patients with COVID-19.

Keywords: COVID‐19; SARS‐COV‐2; mortality; prediction; score; survival.
 
Back
Top Bottom